Prevalence, Impact and Reversibility of Acute Diaprhagmatic Dysfunction in Acute Respiratory Detresse

Last updated: November 20, 2019
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Active - Recruiting

Phase

N/A

Condition

Acute Respiratory Distress Syndrome (Ards)

Lung Injury

Treatment

N/A

Clinical Study ID

NCT04106128
18-PP-15
  • Ages > 18
  • All Genders

Study Summary

The diaphragm is a fine striated muscle with both extra respiratory and respiratory functions. It does most of the breathing work in interaction with the accessory respiratory muscles, the rib cage and the abdomen. Its activity can be measured by the transdiaphragmatic pressure generated by the magnetic stimulation of phrenic nerves (gold standard). It has been shown in the literature that diaphragmatic ultrasound, via the measurement of diaphragmatic excursion and especially the thickening fraction, is an easily accessible, non-invasive, reproducible and relevant technique for evaluating acute diaphragmatic dysfunction in resuscitation patients.

The objective of this project is to evaluate the prevalence of diaphragmatic dysfunction at admission in patients hospitalized in intensive care / respiratory intensive care unit for hypercapnic and/or hypoxic acute respiratory distress and requiring ventilatory support by non-invasive ventilation or high flow oxygen therapy. A subgroup analysis will then be carried out on 3 populations:

  • Hypercapnic exacerbation of chronic obstructive pulmonary disease

  • Hypoxic acute respiratory distress on infectious lung disease

  • Acute pulmonary edema

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Hospitalization for acute respiratory distress management

  • Etiological diagnosis either:

  • Exacerbation of chronic obstructive pulmonary disease

  • Infectious pneumonitis

  • Acute pulmonary edema

  • Need for a ventilatory support by either:

  • Non-invasive ventilation

  • High flow oxygen therapy (flow rate > 40L/min and oxygen inspired fraction > 40%)

  • Mask oxygen therapy with flow rate > 5L/min

Exclusion

Exclusion Criteria:

  • Exacerbation of interstitial pathology / pulmonary fibrosis

  • Deformation of the thoracic cage

  • Neurodegenerative pathology

  • Need for oro-tracheal intubation from the beginning for mechanical ventilation

  • Contraindication to Non-invasive Ventilation

  • Patients undergoing diaphragmatic rehabilitation

  • Immunocompromised patients

  • History of known diaphragmatic dysfunction

Study Design

Total Participants: 201
Study Start date:
April 05, 2019
Estimated Completion Date:
October 05, 2020

Connect with a study center

  • CHU de Nice

    Nice, 06003
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.